… unstable disease has important therapeutic and prognostic … colorectal cancer, novel
immunotherapies and the interaction of the immune system with each apex of the tripartite of cancer …

… The immune system has a substantial effect on colorectal cancer (CRC) progression. …
therapies) is influenced by the immune system. The molecular characterization of colorectal cancer …

… Colorectal cancer is the third most common cancer and the third cause of cancer death in
western countries [Globocan, 2008]. The main parameter to predict survival or relapse is tumor …

… Despite improvements in early detection and treatment method in recent years, colorectal
cancer (CRC) remains the third most frequent and the fourth leading cause of cancer-…

… , the overall survival rate of cancer has not been improved. Colorectal cancer (CRC) is …
provided promising treatment modalities for effective therapy of cancer. The limitations of …

Background The field of colorectal cancer chemotherapy has been transformed by the advent
of molecule‐specific drugs. Combined use of such drugs enhances tumour response rates…

… -line therapy for metastatic colorectal cancer: NO16966 updated results. Br J Cancer 2011;…
plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-…

… with chemorefractory metastatic colorectal cancer experience … therapeutic resistance,
summarize research efforts aimed to improve patient selection, and present alternative therapeutic …

… Colorectal cancer (CRC) is a public health concern and the second most common type of
cancer … This review provides an overview of recent advances in the search for colorectal cancer …

… signaling pathways that are involved in colorectal cancer (CRC) carcinogenesis. Although
… progression, diagnosis, and therapy with particular emphasis on ROS‐stimulated pathways. …